drugset / Trial / NCT03972358
Assessing Medical Menstrual Regulation in the United States
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the acceptability and use of medical menstrual regulation among women in the United States.
Timeline
- Start
- 2020-02-12
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 200 mg | Oral |
| Subject | Misoprostol | Other / unclassified | 800 ug | Other |